We are live on ! Find out more
ENTL

Entellus Medical, Inc. Common Stock
ENTL

Delisted

ENTL was delisted on the 27th of February, 2018.

0 hedge funds and large institutions have $0 invested in Entellus Medical, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 830 (-83)

100% less funds holding in top 10

Funds holding in top 10: 60 (-6)

100% less capital invested

Capital invested by funds: $441M → $0 (-$441M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 82

Holders
Holders Change
-83
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
82
Calls
Puts
Net Calls
Net Calls Change

ENTL Hedge Fund Activity: Q1 2018 in Review

0 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q1 2018, worth a combined $0 — down 100% from $441M a quarter earlier.

Sellers outnumbered buyers: 82 funds closed out of ENTL and 0 opened new positions — a net loss of 82 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Essex Woodlands Management, exiting entirely with an estimated $77.6M sold.

  • 0 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q1 2018, down from 83 in Q4 2017.
  • Funds reported $0 of Entellus Medical, Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Entellus Medical, Inc. Common Stock positions in Q1 2018 and 82 closed out, a net change of -82 holders.
  • The largest Entellus Medical, Inc. Common Stock seller in Q1 2018 was Essex Woodlands Management, an estimated $77.6M sold.

Based on aggregated 13F filings for Q1 2018.